NEWS CATEGORY : ALL News Event Press Goods/Services 2024.01.09Press Notice regarding Joint Research Agreement on brand-new Cell Sheets 2023.07.26Press Joint Research and Development Agreement on "Human (Allogeneic) Subcutaneous Adipose Tissue-Derived Mesenchymal Stem Cell Sheet (PAL-222) for Patients with Myopic Chorioretinal Atrophy 2023.03.15Press Notice regarding commencement of first-in-human for clinical trial of human (allogenic) subcutaneous adipose tissue derived mesenchymal stem cell sheet (PAL-222) transplantation for myopic chorioretinal atrophy – Phase 1/2a clinical trial (PAMyCA Study) 2022.12.12Press Notice regarding Joint Development of Manufacturing Equipment and Materials for “Cell Sheets” 2021.02.09Press First-in-Human trial on human (autologous) iris pigment epithelial cell sheet transplantation for myopic chorioretinal atrophy has begun recruiting patients at Nagoya City University Hospital. 2020.06.17Press Notice regarding Capital Alliance between PharmaBio Corporation and Alfresa Corporation CONTACT US For more details, questions, and quotes about PharmaBio’s services, please use the email form. MAIL FORM